Hatori, N <br/><br/>
Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass.  [electronic resource] 

 -  Artificial organs  Dec 1994 
 - 904-10 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0160-564X 
<br/><br/><label>Standard No.: </label>10.1111/j.1525-1594.1994.tb03342.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>6-Ketoprostaglandin F1 alpha--blood<br/>Biocompatible Materials--chemistry<br/>Cardiopulmonary Bypass--instrumentation<br/>Complement Activation<br/>Coronary Artery Bypass<br/>Female<br/>Hemoglobins--analysis<br/>Heparin<br/>Humans<br/>Leukocyte Count--drug effects<br/>Leukocyte Elastase<br/>Male<br/>Middle Aged<br/>Oxygenators, Membrane<br/>Pancreatic Elastase--blood<br/>Platelet Activation<br/>Platelet Count--drug effects<br/>Platelet Factor 4--analysis<br/>Protamines--therapeutic use<br/>Surface Properties<br/>Thromboxane B2--blood